Market Research Industry Reports

Agilent Technologies Inc (A) - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company offers its products to diagnostics, life sciences and applied chemical markets. It serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers representatives, resellers and e-commerce. It has research and development (R&D) and manufacturing facilities in the US, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc (A) - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

2
List of Tables 4
List of Figures 6
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Agilent Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Agilent Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 11
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
Agilent Technologies Acquires Product Line Of Aurora SFC Systems 15
Venture Financing 15
Molecular Assemblies Raises USD2.3 Million in Seed Financing 15
Partnerships 16
Agilent Tech Extends its Agreement with University of Leuven - Center for Human Genetics and University Hospitals Leuven 16
Agilent Technologies Enters into Agreement with Transcriptic 17
Agilent Technologies Enters into Distributuion Agreement with PureHoney Technologies 18
Agilent Technologies Enters into Agreement with Bioprocessing Technology Institute 18
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 19
Agilent Technologies And CambTEK Enter Into Co-Marketing Agreement For Sample Prep Technologies 20
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 21
Agilent Technologies Enters Into Co-Marketing Agreement Picometrics 22
Dako Enters Into Co-Development Agreement With Merck 22
Agilent Technologies Enters Into Research Agreement With University of Queensland 23
ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 24
Agilent Enters Into Research Agreement With Daegu Gyeongbuk Institute of Science And Technology 25
Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 25
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 26
Agilent Technologies Enters Into Agreement With University of Rouen And Bioprocessing Technology Institute For Biologics And Vaccine Analysis 27
Agilent Enters Into Research Agreement With Chungnam National University 28
Agilent Technologies Enters Into Agreement With Applied Proteomics 29
Agilent Technologies Enters Into Research Agreement With Centre for Omic Sciences For Systems Biology 30
Agilent Technologies Enters Into Technology Integration Agreement With Premier Biosoft International 31
Agilent Technologies Enters Into Co-Development Agreement With Beijing Genomics Institute 31
Dako Enters Into Co-Development Agreement With Amgen 32
Dako Enters Into Co-Development Agreement With Amgen 33
Dako Enters Into Co-Development Agreement With Bristol-Myers 34
Agilent Technologies And University of Technology Sydney Expand Their Joint Venture 35
Agilent Technologies Enters Into Co-Development Agreement With Chungnam National University 35
Agilent Technologies Enters Into Research And Development Agreement With National University Of Singapore 36
Dako Denmark Enters Into Co-Development Agreement With Epitomics 37
Agilent Technologies Enters Into Co-Marketing Agreement With Sage Science 38
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 39
Licensing Agreements 40
Dako Enters into Licensing Agreement with OriGene Technologies 40
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 41
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 41
Debt Offering 42
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 42
Acquisition 43
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 43
Agilent Technologies Acquires Cartagenia for USD68.34 Million 44
Agilent Technologies To Acquire ABC Instrumentacion Analitica 45
Agilent Technologies Acquires Minority Stake In Gen9 For US$21 Million 46
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 47
Agilent Technologies Completes Acquisition Of BioSystem Development 48
Agilent Technologies Acquires Halo Genomics 49
Agilent Technologies Acquires BIOCIUS Life Sciences 50
Agilent Technologies Inc - Key Competitors 52
Key Employees 53
Locations And Subsidiaries 55
Head Office 55
Other Locations & Subsidiaries 55
Recent Developments 56
Strategy And Business Planning 56
Aug 09, 2016: Agilent Technologies to Build New Facility in Colorado, Increasing Pharmaceutical Manufacturing Capacity 56
Corporate Communications 57
Jul 18, 2017: Hans E. Bishop to Join Agilents Board of Directors 57
Legal and Regulatory 58
May 19, 2016: Twist Bioscience Retains Leading Law Firm Quinn Emanuel to Combat Lawsuit Filed by Agilent Technologies 58
Jan 06, 2016: ENZO Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies 59
Product News 60
Oct 10, 2016: Agilent Technologies showcases innovative laboratory solutions at analytica China 2016 60
Sep 13, 2016: Agilent Technologies Lowers the Cost of Multi-Element Analysis 61
Aug 30, 2016: Agilent Technologies Introduces Transformational Technology for Gas Chromatography 62
Jun 06, 2017: Agilent Technologies Introduces New GC/Q-TOF System Enabling Greater Exploration of Unknown Chemical Samples 63
Jun 06, 2016: Agilent Technologies Launches New Solutions for Pharma, Biopharma, Metabolomics and Environmental Researchers Across Mass Spec Portfolio 64
Jun 05, 2017: Agilent Technologies Announces Revolutionary Triple Quadrupole Mass Spectrometer 65
May 10, 2016: Agilent Technologies Introduces InfinityLab Liquid Chromatography Instruments, Columns and Supplies 66
Apr 18, 2016: Agilent Technologies Introduces First Commercial Software for Metabolic Flux Analysis 67
Mar 21, 2017: Agilent Technologies Enhances Exome Sequencing for Clinical Research 68
Mar 08, 2017: Agilent Technologies Launches New Research-Grade Triple Quadrupole LC/MS System 69
Mar 07, 2017: Agilent Technologies Extends Biopharma Portfolio with Advanced Mass Spec System 70
Other Significant Developments 71
Oct 20, 2016: Agilent Technologies Launches SureGuide CRISPR Libraries for Functional Genomics 71
Feb 11, 2016: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 72
Feb 11, 2016: TRADE NEWS: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics 73
Appendix 74
Methodology 74
About GlobalData 74
Contact Us 74
Disclaimer 74

List Of Tables


Agilent Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Agilent Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Agilent Technologies Inc, Deals By Therapy Area, 2011 to YTD 2017 10
Agilent Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 11
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Agilent Technologies Acquires Product Line Of Aurora SFC Systems 15
Molecular Assemblies Raises USD2.3 Million in Seed Financing 15
Agilent Tech Extends its Agreement with University of Leuven - Center for Human Genetics and University Hospitals Leuven 16
Agilent Technologies Enters into Agreement with Transcriptic 17
Agilent Technologies Enters into Distributuion Agreement with PureHoney Technologies 18
Agilent Technologies Enters into Agreement with Bioprocessing Technology Institute 18
Dako Enters into Development Agreement with ONO PHARMA for Opdivo 19
Agilent Technologies And CambTEK Enter Into Co-Marketing Agreement For Sample Prep Technologies 20
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine 21
Agilent Technologies Enters Into Co-Marketing Agreement Picometrics 22
Dako Enters Into Co-Development Agreement With Merck 22
Agilent Technologies Enters Into Research Agreement With University of Queensland 23
ModiQuest Research Extends Agreement With Dako To Generate Monoclonal Antibody 24
Agilent Enters Into Research Agreement With Daegu Gyeongbuk Institute of Science And Technology 25
Agilent Technologies Enters Into Co-Development Agreement With Seoul National University Hospital 25
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay 26
Agilent Technologies Enters Into Agreement With University of Rouen And Bioprocessing Technology Institute For Biologics And Vaccine Analysis 27
Agilent Enters Into Research Agreement With Chungnam National University 28
Agilent Technologies Enters Into Agreement With Applied Proteomics 29
Agilent Technologies Enters Into Research Agreement With Centre for Omic Sciences For Systems Biology 30
Agilent Technologies Enters Into Technology Integration Agreement With Premier Biosoft International 31
Agilent Technologies Enters Into Co-Development Agreement With Beijing Genomics Institute 31
Dako Enters Into Co-Development Agreement With Amgen 32
Dako Enters Into Co-Development Agreement With Amgen 33
Dako Enters Into Co-Development Agreement With Bristol-Myers 34
Agilent Technologies And University of Technology Sydney Expand Their Joint Venture 35
Agilent Technologies Enters Into Co-Development Agreement With Chungnam National University 35
Agilent Technologies Enters Into Research And Development Agreement With National University Of Singapore 36
Dako Denmark Enters Into Co-Development Agreement With Epitomics 37
Agilent Technologies Enters Into Co-Marketing Agreement With Sage Science 38
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies 39
Dako Enters into Licensing Agreement with OriGene Technologies 40
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology 41
Eppendorf Enters Into Licensing Agreement With Agilent Technologies 41
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million 42
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million 43
Agilent Technologies Acquires Cartagenia for USD68.34 Million 44
Agilent Technologies To Acquire ABC Instrumentacion Analitica 45
Agilent Technologies Acquires Minority Stake In Gen9 For US$21 Million 46
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion 47
Agilent Technologies Completes Acquisition Of BioSystem Development 48
Agilent Technologies Acquires Halo Genomics 49
Agilent Technologies Acquires BIOCIUS Life Sciences 50
Agilent Technologies Inc, Key Competitors 52
Agilent Technologies Inc, Key Employees 53
Agilent Technologies Inc, Subsidiaries 55

List Of Figures


Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Agilent Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Agilent Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 11

Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review

Get detailed information about the company and its operations to identify potential customers and suppliers.

USD 125View Report

Agilent Technologies Inc (A) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and

USD 250View Report

Vertebral Technologies Inc - Product Pipeline Analysis, 2018 Update

Vertebral Technologies Inc (VTI) is a medical equipment company that manufactures and develops implantable spinal devices. The company offers products such as interfuse, interlink, intercushion and intergraft. It provides proven

USD 750View Report

OrthoAccel Technologies Inc - Medical Equipment - Deals and Alliances Profile

OrthoAccel Technologies Inc (AcceleDent) is a medical device company that develops, manufactures and markets dental care and orthodontic treatment products. The companys products comprise acceledent aura is an accelerated tooth

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Jul 2017
No. of Pages :74
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube